Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYMBanks - Regional
+$0.15 today
- Market cap
- $12.16B
- Beta
- 0.76
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$2.54
Volume 5.80M
Average 4.76M
CHYM Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Chime Financial, Inc. Class A Common StockNASDAQ: CHYM
Net Margin · Q2 FY2026 · quarter ended Jun 2026
Net margin widens to 4.8%
Net margin was 4.8% in Q2 FY2026, up 179.7 pp from a year earlier. On a trailing-twelve-month basis it was -0.8%, up 48.2 pp year over year. Over 3 fiscal years it widened by 0.4 pp.
Context
- Net margin widened in 2 of the last 3 fiscal years.
What to watch
Whether net margin reaches the consensus estimate from 16 analysts of 6.5% for the fiscal year ending Dec 2026, up from -46.2% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 4.8%-3.4 pp QoQ
- Last fiscal yearDec 2025
- -46.2%-44.7 pp YoY
- LTMJun 2026
- -0.8%+48.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +179.7 pp | +15.6 pp | -164.1 pp |
| 1 year | -44.7 pp | +52.7 pp | +97.4 pp |
| 3 years | +0.4 pp | +56.3 pp | +55.9 pp |
| 5 years | +72.7 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -46.2%
- Year-over-year change
- -44.7pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -46.2% | -44.7pp |
| FY2024 | 2024-12-31 | -1.5% | +14.4pp |
| FY2023 | 2023-12-31 | -15.9% | +30.7pp |
| FY2022 | 2022-12-31 | -46.6% | — |
Net Margin vs competitors
How CHYM compares with its peers on the latest reported figures
- CHYM's LTM Jun 2026 net margin of -0.8% is the 6th highest of the 7 companies compared; the peer median is 25.0%.
- Its year-over-year change of +48.2 pp is the highest of 7, against a peer median of +1.1 pp.
- Over three fiscal years its change of +0.4 pp compares with a peer median of +21.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 46.3% | +1.4 pp | +1.0 pp | |
| LTM Jun 2026 | 34.6% | +21.9 pp | +98.3 pp | |
| LTM Jun 2026 | 31.1% | +17.5 pp | +43.3 pp | |
| LTM Sep 2026 | 18.8% | +0.7 pp | +26.1 pp | |
| LTM Jun 2026 | 14.4% | -0.1 pp | +7.0 pp | |
| LTM Jun 2026 | -0.8% | +48.2 pp | +0.4 pp | |
| LTM Jun 2026 | -9.4% | -25.5 pp | +16.9 pp | |
| Peer median (excluding CHYM) | 25.0% | +1.1 pp | +21.5 pp | |
Competitors are the stored peer set for CHYM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 1.01B | 1.28B | 1.67B | 2.19B |
| Cost of Revenue | 214.69M | 219.74M | 207.51M | 309.03M |
| Gross Profit | 794.15M | 1.06B | 1.47B | 1.88B |
| Gross Margin | 78.7% | 82.8% | 87.6% | 85.9% |
| Research & Development | 242.43M | 259M | 309.58M | 934.93M |
| Selling, General & Admin | 603.94M | 598.75M | 696.99M | 1.15B |
| Operating Expenses | 1.27B | 1.29B | 1.53B | 2.92B |
| Depreciation & Amortization | 7.3M | 12.94M | 25.37M | 30M |
| EBITDA | (471.4M) | (222.85M) | (36.83M) | (979.11M) |
| EBITDA Margin | -46.7% | -17.4% | -2.2% | -44.8% |
| Operating Income | (478.7M) | (235.79M) | (62.2M) | (1.04B) |
| Operating Margin | -47.5% | -18.4% | -3.7% | -47.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 8.11M | 32.82M | 39.47M | 30.87M |
| Income Before Tax | (470.59M) | (202.97M) | (22.73M) | (1.01B) |
| Pre-Tax Margin | -46.6% | -15.9% | -1.4% | -46.1% |
| Income Tax Expense | (337K) | 234K | 2.61M | 831K |
| Net Income | (470.25M) | (203.2M) | (25.34M) | (1.01B) |
| Net Margin | -46.6% | -15.9% | -1.5% | -46.2% |
| EPS (Basic) | (1.29) | (0.56) | (0.07) | (2.67) |
| EPS (Diluted) | (1.29) | (0.56) | (0.07) | (2.60) |
| Weighted Avg Shares | 364.42M | 364.42M | 364.42M | 378.75M |
| Weighted Avg Shares (Diluted) | 364.42M | 364.42M | 364.42M | 388.17M |
Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYM
Intrinsic Alpha fair value
Locked
Current Price
$32.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.